These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1525262)

  • 21. Distinction between 'A'-esterases and arylesterases. Implications for esterase classification.
    Mackness MI; Thompson HM; Hardy AR; Walker CH
    Biochem J; 1987 Jul; 245(1):293-6. PubMed ID: 2822017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation.
    Reiner E; Svedruzic D; Simeon-Rudolf V; Lipovac V; Gavella M; Mrzljak V
    Chem Biol Interact; 1999 May; 119-120():405-11. PubMed ID: 10421477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The thioesterase I of Escherichia coli has arylesterase activity and shows stereospecificity for protease substrates.
    Lee YL; Chen JC; Shaw JF
    Biochem Biophys Res Commun; 1997 Feb; 231(2):452-6. PubMed ID: 9070299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assay of serum arylesterase activity by fitting to the reaction curve with an integrated rate equation.
    Liao F; Liu WL; Zhou QX; Zeng ZC; Zuo YP
    Clin Chim Acta; 2001 Dec; 314(1-2):67-76. PubMed ID: 11718680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
    Bayrak A; Bayrak T; Demirpençe E; Kılınç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Oxo-1,3-dioxoles as specific substrates for measurement of arylesterase activity.
    Kawai H; Sakamoto F; Taguchi M; Kitamura M; Sotomura M; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1422-5. PubMed ID: 1934162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of aryl esterase activity in the human serum using 4-nitrophenyl acetate].
    Koch CD; Block H; Molz J
    Z Gastroenterol; 1975 Dec; 13(8):695-703. PubMed ID: 1224758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arylesterase activity and total serum esterolytic activity in infants with pneumonia].
    Nowak J; Szafran Z; Grabczyńska-Amborska H
    Pediatr Pol; 1982 Dec; 57(12):1023-7. PubMed ID: 7182778
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular characterization of a novel arylesterase from the wine-associated acetic acid bacterium Gluconobacter oxidans 621H.
    Navarro-González I; Sánchez-Ferrer Á; García-Carmona F
    J Agric Food Chem; 2012 Oct; 60(43):10789-95. PubMed ID: 23003572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distribution of esterases in the skin of the minipig.
    Jewell C; Prusakiewicz JJ; Ackermann C; Payne NA; Fate G; Williams FM
    Toxicol Lett; 2007 Sep; 173(2):118-23. PubMed ID: 17719730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human serum arylesterase by metal chlorides.
    Debord J; Bollinger JC; Merle L; Dantoine T
    J Inorg Biochem; 2003 Feb; 94(1-2):1-4. PubMed ID: 12620667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
    Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
    Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.
    Bargota RS; Akhtar M; Biggadike K; Gani D; Allemann RK
    Bioorg Med Chem Lett; 2003 May; 13(10):1623-6. PubMed ID: 12729627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 4-nitrophenyl caffeate and its use in assays of caffeoyl esterases.
    Chyba A; Mastihuba V; Mastihubová M
    Anal Biochem; 2014 Jan; 445():49-53. PubMed ID: 24135652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arylesterase isoenzymes and activity in normal healthy adults and in patients with cancer and with other diseases.
    Lie-Injo LE; Solai A; Ganesan J; Ganesan S
    Clin Biochem; 1980 Jun; 13(3):113-5. PubMed ID: 7418194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
    Dirican M; Taş S; Sarandöl E
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):833-7. PubMed ID: 17645625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
    La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
    Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights on the specificity of penicillin acylase.
    Roa A; Castillón MP; Goble ML; Virden R; García JL
    Biochem Biophys Res Commun; 1995 Jan; 206(2):629-36. PubMed ID: 7826381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs.
    Tvarijonaviciute A; Tecles F; Caldin M; Tasca S; Cerón J
    Am J Vet Res; 2012 Jan; 73(1):34-41. PubMed ID: 22204286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.